• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Amgen

repatha
Pharma

Amgen doesn't think Repatha's sales wins will stop anytime soon

With Repatha and several other key growth drivers, Amgen has outpaced declines from biosimilar competition to key brands in Q2.
Fraiser Kansteiner Aug 4, 2026 4:01pm
Data security and privacy concept

Amgen says patient data, IP stolen in cybersecurity breach

Aug 3, 2026 11:05am
Amgens Jay Bradner and MrBeast

Amgen joins MrBeast, Stand Up to Cancer in pediatric cancer mission

Jul 30, 2026 10:46am
Tavneos

Amgen submits analyses to FDA in bid for Tavneos hearing

Jul 24, 2026 10:50am
Amgen Puerto Rico

Investors, Amgen agree to resolve tax bill lawsuit for $74M

Jul 21, 2026 3:53pm
Merck  Co

FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra

Jul 16, 2026 9:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings